Matthew Masucci
analystMale0.0Global Dominance: 0.00%
Matthew Masucci is an analyst for Callodine Capital, where he emphasizes the historical stability and long-term outlook of major pharmaceutical companies, arguing that they do not base their investment strategies on short-term political trends.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Matthew Masucci is an analyst for Callodine Capital who mentioned the long-term investment perspective of vaccine companies.
Drugmakers take hit from the US’ anti-vax changesTaipei Times – major English newspaper in Taiwan, est. 1999·
Taiwan· 2026-01-25
Taiwan· 2026-01-25
